• レポートコード:QFJ1-4349 • 出版社/出版日:QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態:英文、PDF、85ページ • 納品方法:Eメール(納期:3日) • 産業分類:医療 |
Single User | ¥585,000 (USD3,900) | ▷ お問い合わせ |
Multi User | ¥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査レポートでは、免疫腫瘍学アッセイの世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(イムノアッセイ、フローサイトメトリー、PCR、次世代シーケンシング)、用途別市場規模(研究所、臨床診断)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。 ・市場概要 ・免疫腫瘍学アッセイの市場動向 ・企業の競争状況、市場シェア ・免疫腫瘍学アッセイの種類別市場規模と予測2016-2027(イムノアッセイ、フローサイトメトリー、PCR、次世代シーケンシング) ・免疫腫瘍学アッセイの用途別市場規模と予測2016-2027(研究所、臨床診断) ・免疫腫瘍学アッセイの北米市場規模2016-2027(アメリカ、カナダ) ・免疫腫瘍学アッセイの欧州市場規模2016-2027(ドイツ、フランス、イギリス等) ・免疫腫瘍学アッセイのアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等) ・免疫腫瘍学アッセイの中南米市場規模2016-2027(メキシコ、ブラジル) ・免疫腫瘍学アッセイの中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等) ・主要企業情報(Thermo Fischer Scientific、Roche Diagnostics、Agilent Technologies、Illumina) ・結論 |
Immuno-Oncology Assays Accelerate Cancer Immunotherapy enable fast, effective, and clinically relevant understanding of immuno-oncology targets, pathways and mechanisms, enabling quicker development of immuno-oncology drugs. Learn how you can rapidly screen and develop antibodies targeting checkpoint receptors, bi-specific antibodies, small molecules, or cellular therapies such as chimeric antigen receptor T-cells (CAR-T).
Market Analysis and Insights: Global Immuno Oncology Assays Market
The global Immuno Oncology Assays market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Immuno Oncology Assays market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Immuno Oncology Assays market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Immuno Oncology Assays market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Immuno Oncology Assays market.
Global Immuno Oncology Assays Scope and Market Size
Immuno Oncology Assays market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Immuno Oncology Assays market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast and in terms of revenue and forecast for the period 2016-2027.
Segment
Immunoassay
Flow Cytometry
PCR
Next Generation Sequencing
Segment
Research
Clinical Diagnostics
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Thermo Fischer Scientific
Roche Diagnostics
Agilent Technologies
Illumina
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immuno Oncology Assays Market Size Growth Rate : 2016 VS 2021 VS 2027
1.2.2 Immunoassay
1.2.3 Flow Cytometry
1.2.4 PCR
1.2.5 Next Generation Sequencing
1.3 Market by Application
1.3.1 Global Immuno Oncology Assays Market Share : 2016 VS 2021 VS 2027
1.3.2 Research
1.3.3 Clinical Diagnostics
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Immuno Oncology Assays Market Perspective (2016-2027)
2.2 Immuno Oncology Assays Growth Trends by Regions
2.2.1 Immuno Oncology Assays Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Immuno Oncology Assays Historic Market Share by Regions (2016-2021)
2.2.3 Immuno Oncology Assays Forecasted Market Size by Regions (2022-2027)
2.3 Immuno Oncology Assays Industry Dynamic
2.3.1 Immuno Oncology Assays Market Trends
2.3.2 Immuno Oncology Assays Market Drivers
2.3.3 Immuno Oncology Assays Market Challenges
2.3.4 Immuno Oncology Assays Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immuno Oncology Assays Players by Revenue
3.1.1 Global Top Immuno Oncology Assays Players by Revenue (2016-2021)
3.1.2 Global Immuno Oncology Assays Revenue Market Share by Players (2016-2021)
3.2 Global Immuno Oncology Assays Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Immuno Oncology Assays Revenue
3.4 Global Immuno Oncology Assays Market Concentration Ratio
3.4.1 Global Immuno Oncology Assays Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immuno Oncology Assays Revenue in 2020
3.5 Immuno Oncology Assays Key Players Head office and Area Served
3.6 Key Players Immuno Oncology Assays Product Solution and Service
3.7 Date of Enter into Immuno Oncology Assays Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immuno Oncology Assays Breakdown Data
4.1 Global Immuno Oncology Assays Historic Market Size (2016-2021)
4.2 Global Immuno Oncology Assays Forecasted Market Size (2022-2027)
5 Immuno Oncology Assays Breakdown Data
5.1 Global Immuno Oncology Assays Historic Market Size (2016-2021)
5.2 Global Immuno Oncology Assays Forecasted Market Size (2022-2027)
6 North America
6.1 North America Immuno Oncology Assays Market Size (2016-2027)
6.2 North America Immuno Oncology Assays Market Size
6.2.1 North America Immuno Oncology Assays Market Size (2016-2021)
6.2.2 North America Immuno Oncology Assays Market Size (2022-2027)
6.2.3 North America Immuno Oncology Assays Market Size (2016-2027)
6.3 North America Immuno Oncology Assays Market Size
6.3.1 North America Immuno Oncology Assays Market Size (2016-2021)
6.3.2 North America Immuno Oncology Assays Market Size (2022-2027)
6.3.3 North America Immuno Oncology Assays Market Size (2016-2027)
6.4 North America Immuno Oncology Assays Market Size by Country
6.4.1 North America Immuno Oncology Assays Market Size by Country (2016-2021)
6.4.2 North America Immuno Oncology Assays Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Immuno Oncology Assays Market Size (2016-2027)
7.2 Europe Immuno Oncology Assays Market Size
7.2.1 Europe Immuno Oncology Assays Market Size (2016-2021)
7.2.2 Europe Immuno Oncology Assays Market Size (2022-2027)
7.2.3 Europe Immuno Oncology Assays Market Size (2016-2027)
7.3 Europe Immuno Oncology Assays Market Size
7.3.1 Europe Immuno Oncology Assays Market Size (2016-2021)
7.3.2 Europe Immuno Oncology Assays Market Size (2022-2027)
7.3.3 Europe Immuno Oncology Assays Market Size (2016-2027)
7.4 Europe Immuno Oncology Assays Market Size by Country
7.4.1 Europe Immuno Oncology Assays Market Size by Country (2016-2021)
7.4.2 Europe Immuno Oncology Assays Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Immuno Oncology Assays Market Size (2016-2027)
8.2 Asia-Pacific Immuno Oncology Assays Market Size
8.2.1 Asia-Pacific Immuno Oncology Assays Market Size (2016-2021)
8.2.2 Asia-Pacific Immuno Oncology Assays Market Size (2022-2027)
8.2.3 Asia-Pacific Immuno Oncology Assays Market Size (2016-2027)
8.3 Asia-Pacific Immuno Oncology Assays Market Size
8.3.1 Asia-Pacific Immuno Oncology Assays Market Size (2016-2021)
8.3.2 Asia-Pacific Immuno Oncology Assays Market Size (2022-2027)
8.3.3 Asia-Pacific Immuno Oncology Assays Market Size (2016-2027)
8.4 Asia-Pacific Immuno Oncology Assays Market Size by Region
8.4.1 Asia-Pacific Immuno Oncology Assays Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Immuno Oncology Assays Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Immuno Oncology Assays Market Size (2016-2027)
9.2 Latin America Immuno Oncology Assays Market Size
9.2.1 Latin America Immuno Oncology Assays Market Size (2016-2021)
9.2.2 Latin America Immuno Oncology Assays Market Size (2022-2027)
9.2.3 Latin America Immuno Oncology Assays Market Size (2016-2027)
9.3 Latin America Immuno Oncology Assays Market Size
9.3.1 Latin America Immuno Oncology Assays Market Size (2016-2021)
9.3.2 Latin America Immuno Oncology Assays Market Size (2022-2027)
9.3.3 Latin America Immuno Oncology Assays Market Size (2016-2027)
9.4 Latin America Immuno Oncology Assays Market Size by Country
9.4.1 Latin America Immuno Oncology Assays Market Size by Country (2016-2021)
9.4.2 Latin America Immuno Oncology Assays Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immuno Oncology Assays Market Size (2016-2027)
10.2 Middle East & Africa Immuno Oncology Assays Market Size
10.2.1 Middle East & Africa Immuno Oncology Assays Market Size (2016-2021)
10.2.2 Middle East & Africa Immuno Oncology Assays Market Size (2022-2027)
10.2.3 Middle East & Africa Immuno Oncology Assays Market Size (2016-2027)
10.3 Middle East & Africa Immuno Oncology Assays Market Size
10.3.1 Middle East & Africa Immuno Oncology Assays Market Size (2016-2021)
10.3.2 Middle East & Africa Immuno Oncology Assays Market Size (2022-2027)
10.3.3 Middle East & Africa Immuno Oncology Assays Market Size (2016-2027)
10.4 Middle East & Africa Immuno Oncology Assays Market Size by Country
10.4.1 Middle East & Africa Immuno Oncology Assays Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Immuno Oncology Assays Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Thermo Fischer Scientific
11.1.1 Thermo Fischer Scientific Company Details
11.1.2 Thermo Fischer Scientific Business Overview
11.1.3 Thermo Fischer Scientific Immuno Oncology Assays Introduction
11.1.4 Thermo Fischer Scientific Revenue in Immuno Oncology Assays Business (2016-2021)
11.1.5 Thermo Fischer Scientific Recent Development
11.2 Roche Diagnostics
11.2.1 Roche Diagnostics Company Details
11.2.2 Roche Diagnostics Business Overview
11.2.3 Roche Diagnostics Immuno Oncology Assays Introduction
11.2.4 Roche Diagnostics Revenue in Immuno Oncology Assays Business (2016-2021)
11.2.5 Roche Diagnostics Recent Development
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Details
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies Immuno Oncology Assays Introduction
11.3.4 Agilent Technologies Revenue in Immuno Oncology Assays Business (2016-2021)
11.3.5 Agilent Technologies Recent Development
11.4 Illumina
11.4.1 Illumina Company Details
11.4.2 Illumina Business Overview
11.4.3 Illumina Immuno Oncology Assays Introduction
11.4.4 Illumina Revenue in Immuno Oncology Assays Business (2016-2021)
11.4.5 Illumina Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Immuno Oncology Assays Market Size Growth Rate (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Immunoassay
Table 3. Key Players of Flow Cytometry
Table 4. Key Players of PCR
Table 5. Key Players of Next Generation Sequencing
Table 6. Global Immuno Oncology Assays Market Size Growth (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Immuno Oncology Assays Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Immuno Oncology Assays Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Immuno Oncology Assays Market Share by Regions (2016-2021)
Table 10. Global Immuno Oncology Assays Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Immuno Oncology Assays Market Share by Regions (2022-2027)
Table 12. Immuno Oncology Assays Market Trends
Table 13. Immuno Oncology Assays Market Drivers
Table 14. Immuno Oncology Assays Market Challenges
Table 15. Immuno Oncology Assays Market Restraints
Table 16. Global Immuno Oncology Assays Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Immuno Oncology Assays Market Share by Players (2016-2021)
Table 18. Global Top Immuno Oncology Assays Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immuno Oncology Assays as of 2020)
Table 19. Ranking of Global Top Immuno Oncology Assays Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Immuno Oncology Assays Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Immuno Oncology Assays Product Solution and Service
Table 23. Date of Enter into Immuno Oncology Assays Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Immuno Oncology Assays Market Size (2016-2021) (US$ Million)
Table 26. Global Immuno Oncology Assays Revenue Market Share (2016-2021)
Table 27. Global Immuno Oncology Assays Forecasted Market Size (2022-2027) (US$ Million)
Table 28. Global Immuno Oncology Assays Revenue Market Share (2022-2027) & (US$ Million)
Table 29. Global Immuno Oncology Assays Market Size Share (2016-2021) & (US$ Million)
Table 30. Global Immuno Oncology Assays Revenue Market Share (2016-2021)
Table 31. Global Immuno Oncology Assays Forecasted Market Size (2022-2027) (US$ Million)
Table 32. Global Immuno Oncology Assays Revenue Market Share (2022-2027) & (US$ Million)
Table 33. North America Immuno Oncology Assays Market Size (2016-2021) (US$ Million)
Table 34. North America Immuno Oncology Assays Market Size (2022-2027) & (US$ Million)
Table 35. North America Immuno Oncology Assays Market Size (2016-2021) (US$ Million)
Table 36. North America Immuno Oncology Assays Market Size (2022-2027) & (US$ Million)
Table 37. North America Immuno Oncology Assays Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Immuno Oncology Assays Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Immuno Oncology Assays Market Size (2016-2021) (US$ Million)
Table 40. Europe Immuno Oncology Assays Market Size (2022-2027) & (US$ Million)
Table 41. Europe Immuno Oncology Assays Market Size (2016-2021) (US$ Million)
Table 42. Europe Immuno Oncology Assays Market Size (2022-2027) & (US$ Million)
Table 43. Europe Immuno Oncology Assays Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Immuno Oncology Assays Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Immuno Oncology Assays Market Size (2016-2021) (US$ Million)
Table 46. Asia-Pacific Immuno Oncology Assays Market Size (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Immuno Oncology Assays Market Size (2016-2021) (US$ Million)
Table 48. Asia-Pacific Immuno Oncology Assays Market Size (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Immuno Oncology Assays Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Immuno Oncology Assays Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Immuno Oncology Assays Market Size (2016-2021) (US$ Million)
Table 52. Latin America Immuno Oncology Assays Market Size (2022-2027) & (US$ Million)
Table 53. Latin America Immuno Oncology Assays Market Size (2016-2021) (US$ Million)
Table 54. Latin America Immuno Oncology Assays Market Size (2022-2027) & (US$ Million)
Table 55. Latin America Immuno Oncology Assays Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Immuno Oncology Assays Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Immuno Oncology Assays Market Size (2016-2021) (US$ Million)
Table 58. Middle East & Africa Immuno Oncology Assays Market Size (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Immuno Oncology Assays Market Size (2016-2021) (US$ Million)
Table 60. Middle East & Africa Immuno Oncology Assays Market Size (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Immuno Oncology Assays Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Immuno Oncology Assays Market Size by Country (2022-2027) & (US$ Million)
Table 63. Thermo Fischer Scientific Company Details
Table 64. Thermo Fischer Scientific Business Overview
Table 65. Thermo Fischer Scientific Immuno Oncology Assays Product
Table 66. Thermo Fischer Scientific Revenue in Immuno Oncology Assays Business (2016-2021) & (US$ Million)
Table 67. Thermo Fischer Scientific Recent Development
Table 68. Roche Diagnostics Company Details
Table 69. Roche Diagnostics Business Overview
Table 70. Roche Diagnostics Immuno Oncology Assays Product
Table 71. Roche Diagnostics Revenue in Immuno Oncology Assays Business (2016-2021) & (US$ Million)
Table 72. Roche Diagnostics Recent Development
Table 73. Agilent Technologies Company Details
Table 74. Agilent Technologies Business Overview
Table 75. Agilent Technologies Immuno Oncology Assays Product
Table 76. Agilent Technologies Revenue in Immuno Oncology Assays Business (2016-2021) & (US$ Million)
Table 77. Agilent Technologies Recent Development
Table 78. Illumina Company Details
Table 79. Illumina Business Overview
Table 80. Illumina Immuno Oncology Assays Product
Table 81. Illumina Revenue in Immuno Oncology Assays Business (2016-2021) & (US$ Million)
Table 82. Illumina Recent Development
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immuno Oncology Assays Market Share : 2020 VS 2027
Figure 2. Immunoassay Features
Figure 3. Flow Cytometry Features
Figure 4. PCR Features
Figure 5. Next Generation Sequencing Features
Figure 6. Global Immuno Oncology Assays Market Share : 2020 VS 2027
Figure 7. Research Case Studies
Figure 8. Clinical Diagnostics Case Studies
Figure 9. Immuno Oncology Assays Report Years Considered
Figure 10. Global Immuno Oncology Assays Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Immuno Oncology Assays Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Immuno Oncology Assays Market Share by Regions: 2020 VS 2027
Figure 13. Global Immuno Oncology Assays Market Share by Regions (2022-2027)
Figure 14. Global Immuno Oncology Assays Market Share by Players in 2020
Figure 15. Global Top Immuno Oncology Assays Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immuno Oncology Assays as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Immuno Oncology Assays Revenue in 2020
Figure 17. Global Immuno Oncology Assays Revenue Market Share (2016-2021)
Figure 18. Global Immuno Oncology Assays Revenue Market Share (2022-2027)
Figure 19. North America Immuno Oncology Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Immuno Oncology Assays Market Share (2016-2027)
Figure 21. North America Immuno Oncology Assays Market Share (2016-2027)
Figure 22. North America Immuno Oncology Assays Market Share by Country (2016-2027)
Figure 23. United States Immuno Oncology Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Immuno Oncology Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Immuno Oncology Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Immuno Oncology Assays Market Share (2016-2027)
Figure 27. Europe Immuno Oncology Assays Market Share (2016-2027)
Figure 28. Europe Immuno Oncology Assays Market Share by Country (2016-2027)
Figure 29. Germany Immuno Oncology Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Immuno Oncology Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Immuno Oncology Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Immuno Oncology Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Immuno Oncology Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Immuno Oncology Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Immuno Oncology Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Immuno Oncology Assays Market Share (2016-2027)
Figure 37. Asia-Pacific Immuno Oncology Assays Market Share (2016-2027)
Figure 38. Asia-Pacific Immuno Oncology Assays Market Share by Region (2016-2027)
Figure 39. China Immuno Oncology Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Immuno Oncology Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Immuno Oncology Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Immuno Oncology Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Immuno Oncology Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Immuno Oncology Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Immuno Oncology Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Immuno Oncology Assays Market Share (2016-2027)
Figure 47. Latin America Immuno Oncology Assays Market Share (2016-2027)
Figure 48. Latin America Immuno Oncology Assays Market Share by Country (2016-2027)
Figure 49. Mexico Immuno Oncology Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Immuno Oncology Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Immuno Oncology Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Immuno Oncology Assays Market Share (2016-2027)
Figure 53. Middle East & Africa Immuno Oncology Assays Market Share (2016-2027)
Figure 54. Middle East & Africa Immuno Oncology Assays Market Share by Country (2016-2027)
Figure 55. Turkey Immuno Oncology Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Immuno Oncology Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Immuno Oncology Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Thermo Fischer Scientific Revenue Growth Rate in Immuno Oncology Assays Business (2016-2021)
Figure 59. Roche Diagnostics Revenue Growth Rate in Immuno Oncology Assays Business (2016-2021)
Figure 60. Agilent Technologies Revenue Growth Rate in Immuno Oncology Assays Business (2016-2021)
Figure 61. Illumina Revenue Growth Rate in Immuno Oncology Assays Business (2016-2021)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed